Nuclear translocation of phosphorylated STAT3 regulates VEGF-A-induced lymphatic endothelial cell migration and tube formation

Biochemical and Biophysical Research Communications

Volumn 412, Issue 3, 2011, Pages 441-445

  Okazaki, Hideki ^a   Tokumaru, Sho ^a   Hanakawa, Yasushi ^a   Shiraishi, Ken ^a   Shirakata, Yuji ^a   Dai, Xiuju ^a   Yang, Lijun ^a   Tohyama, Mikiko ^a   Hashimoto, Koji ^a   Sayama, Koji ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Lymphatic endothelial cell; Migration; STAT1; STAT3; Tube formation; VEGF

Indexed keywords

ADENOVIRUS VECTOR; MATRIGEL; STAT3 PROTEIN; VASCULOTROPIN A;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEAR TRANSLOCATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUBE FORMATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL MOVEMENT; CELL NUCLEUS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; LYMPHATIC VESSELS; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE;

EID: 80052273376     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.111     Document Type: Article

References (43)

1. Dermatology 2003, Mosby, London. first ed. J.L. Bolognia, J.L. Jorizzo, R.P. Rapini (Eds.).
2. Liersch R., Detmar M. Lymphangiogenesis in development and disease. Thromb. Haemost. 2007, 98:304-310.
3. Hirakawa S. Regulation of pathological lymphangiogenesis requires factors distinct from those governing physiological lymphangiogenesis. J. Dermatol. Sci. 2010, 61:85-93.
4. Jackson D.G. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004, 112:526-538.
5. Hong Y.K., Detmar M. Prox1, master regulator of the lymphatic vasculature phenotype. Cell Tissue Res. 2003, 314:85-92.
6. Ordonez N.G. Podoplanin: a novel diagnostic immunohistochemical marker. Adv. Anat. Pathol. 2006, 13:83-88.
7. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997, 18:4-25.
8. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 1999, 56:794-814.
9. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999, 13:9-22.
10. Ortega N., Hutchings H., Plouet J. Signal relays in the VEGF system. Front. Biosci. 1999, 4:D141-152.
11. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., Breitman M., Alitalo K. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science (New York, NY) 1998, 282:946-949.
12. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74.
13. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
14. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (New York, NY) 1992, 255:989-991.
15. Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S., Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995, 10:135-147.
16. Terman B.I., Carrion M.E., Kovacs E., Rasmussen B.A., Eddy R.L., Shows T.B. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991, 6:1677-1683.
17. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 1992, 187:1579-1586.
18. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 1994, 269:26988-26995.
19. Landgren E., Schiller P., Cao Y., Claesson-Welsh L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 1998, 16:359-367.
20. Shalaby F., Ho J., Stanford W.L., Fischer K.D., Schuh A.C., Schwartz L., Bernstein A., Rossant J. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997, 89:981-990.
21. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70.
22. Vaisman N., Gospodarowicz D., Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem. 1990, 265:19461-19466.
23. Rousseau S., Houle F., Landry J., Huot J. P38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997, 15:2169-2177.
24. Bartoli M., Gu X., Tsai N.T., Venema R.C., Brooks S.E., Marrero M.B., Caldwell R.B. Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J. Biol. Chem. 2000, 275:33189-33192.
25. Funamoto M., Fujio Y., Kunisada K., Negoro S., Tone E., Osugi T., Hirota H., Izumi M., Yoshizaki K., Walsh K., Kishimoto T., Yamauchi-Takihara K. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J. Biol. Chem. 2000, 275:10561-10566.
26. Yamauchi-Takihara K., Kishimoto T. A novel role for STAT3 in cardiac remodeling. Trends Cardiovasc. Med. 2000, 10:298-303.
27. Darnell J.E. STATs and gene regulation. Science (New York, NY) 1997, 277:1630-1635.
28. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (New York, NY) 1994, 264:1415-1421.
29. Ihle J.N. STATs: signal transducers and activators of transcription. Cell 1996, 84:331-334.
30. Sano S., Itami S., Takeda K., Tarutani M., Yamaguchi Y., Miura H., Yoshikawa K., Akira S., Takeda J. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999, 18:4657-4668.
31. Boccaccio C., Ando M., Tamagnone L., Bardelli A., Michieli P., Battistini C., Comoglio P.M. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 1998, 391:285-288.
32. Yahata Y., Shirakata Y., Tokumaru S., Yamasaki K., Sayama K., Hanakawa Y., Detmar M., Hashimoto K. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J. Biol. Chem. 2003, 278:40026-40031.
33. Tokumaru S., Higashiyama S., Endo T., Nakagawa T., Miyagawa J.I., Yamamori K., Hanakawa Y., Ohmoto H., Yoshino K., Shirakata Y., Matsuzawa Y., Hashimoto K., Taniguchi N. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 2000, 151:209-220.
34. Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J., Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science (New York, NY) 1984, 223:1296-1299.
35. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 1989, 161:851-858.
36. Simorre-Pinatel V., Guerrin M., Chollet P., Penary M., Clamens S., Malecaze F., Plouet J. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest. Ophthalmol. Vis. Sci. 1994, 35:3393-3400.
37. Rifkin D.B., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 1989, 109:1-6.
38. Yoshida A., Anand-Apte B., Zetter B.R. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 1996, 13:57-64.
39. Hong Y.K., Lange-Asschenfeldt B., Velasco P., Hirakawa S., Kunstfeld R., Brown L.F., Bohlen P., Senger D.R., Detmar M. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 2004, 18:1111-1113.
40. Van Trappen P.O., Steele D., Lowe D.G., Baithun S., Beasley N., Thiele W., Weich H., Krishnan J., Shepherd J.H., Pepper M.S., Jackson D.G., Sleeman J.P., Jacobs I.J. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J. Pathol. 2003, 201:544-554.
41. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001, 7:192-198.
42. Johnson H.M., Torres B.A., Green M.M., Szente B.E., Siler K.I., Larkin J., Subramaniam P.S. Cytokine-receptor complexes as chaperones for nuclear translocation of signal transducers. Biochem. Biophys. Res. Commun. 1998, 244:607-614.
43. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl Acad. Sci. USA 1997, 94:3801-3804.